Skip to main content
. 2016 May 24;5:F1000 Faculty Rev-990. [Version 1] doi: 10.12688/f1000research.8245.1

Table 1. Open questions in the cannabinoid receptor-1 (CB 1) receptor field.

Open questions in the endocannabinoid field.
Is the cell type-specific CB 1 receptor signaling an open door to
develop new therapeutic tools?
Is the endocannabinoid system exclusively a retrograde
neuromodulator system?
How is the subcellular CB 1 receptor distributed in the different
cell types?
How can CB 1 receptors control neurotransmitter co-release?
Which physiological and pathological functions are modulated
by intracellular CB 1 receptors?
Is there specific or differential CB 2 receptor expression in
different cell types?
Is the allosteric modulation of CB 1 receptors a good therapeutic
approach for pathological conditions?
Will it be possible to create compounds that target CB 1 receptors
in specific cell types or subcellular localizations?

CB 1, cannabinoid receptor-1; CB 2, cannabinoid receptor-2.